Cellulite Changes: What Could Be Causing It

Why Cellulite Appearance Shifts Over Time

Cellulite is not static. The dimpled texture you notice on your thighs, buttocks, or abdomen reflects a dynamic interaction between subcutaneous fat lobules, fibrous connective tissue septae, and the overlying dermis. When any component of that triad changes, the surface appearance follows.

A 2004 review published in the Journal of the American Academy of Dermatology defined cellulite as a "localized metabolic disorder of subcutaneous tissue that provokes an alteration in female body shape" [1]. The review documented that vertical septae in women (compared to crisscross septae in men) create chambers where fat can herniate upward against the skin surface, producing visible dimples. This anatomical sex difference explains why 80 to 90 percent of women develop some degree of cellulite after puberty, while men rarely do [1].

What most people describe as "cellulite changes" falls into one of several categories: new dimpling where skin was previously smooth, worsening of existing texture, a shift in distribution pattern, or (less commonly) improvement. Each pattern points to a different underlying driver. The Nürnberger-Müller classification grades severity from 0 (no visible dimpling, even with pinch test) through 3 (visible dimpling at rest with nodular texture) [2]. Tracking your grade over time gives clinicians a baseline for identifying what changed and why.

Hormonal Fluctuations and Estrogen's Role

Estrogen is the single most influential hormone governing cellulite severity. Declining estrogen reduces dermal thickness, slows collagen synthesis, and shifts fat storage patterns toward areas where cellulite is most visible.

During the menopausal transition, circulating estradiol levels drop by roughly 60 percent over a 2 to 3 year window [3]. This decline triggers measurable changes in skin structure. A study in the American Journal of Clinical Dermatology found that postmenopausal skin loses approximately 2 percent of its collagen content per year for the first 5 years after menopause, with a parallel decrease in dermal thickness of 1.13 percent annually [4]. Thinner skin with less collagen makes underlying fat herniation more visible at the surface.

Dr. Valerie Callender, a board-certified dermatologist at Howard University, noted in a 2019 clinical review: "Estrogen modulates adipocyte metabolism, collagen cross-linking, and glycosaminoglycan deposition in the dermis. Its withdrawal creates a permissive environment for cellulite progression" [5]. This explains why many women report sudden worsening of cellulite during perimenopause even without weight gain.

Hormonal contraceptives, pregnancy, and polycystic ovary syndrome (PCOS) also alter the estrogen-progesterone balance. Pregnancy increases estrogen 30-fold by the third trimester and simultaneously expands subcutaneous fat stores, which is why new cellulite often appears during the second and third trimesters [3].

Weight Gain, Weight Loss, and Fat Distribution

Body composition changes are the most straightforward cause of cellulite worsening. Gaining fat increases lobule volume; losing fat can paradoxically increase skin laxity. Both paths alter dimpling.

A prospective cohort study of 356 women published in the Journal of the European Academy of Dermatology and Venereology found that women who gained more than 5 kg over a 3-year follow-up period had a 1.4 times higher likelihood of progressing one full Nürnberger-Müller grade compared to weight-stable controls [2]. The relationship was not purely linear. Women with a BMI above 30 showed more visible cellulite than those with a BMI between 25 and 30, but thin women with a BMI under 22 also exhibited cellulite when their septae architecture was genetically unfavorable [2].

Rapid weight loss creates a different problem. When subcutaneous fat volume decreases quickly, the overlying skin may not retract proportionally, leaving loose, crepey texture that makes residual dimpling more prominent. A 2021 analysis in Plastic and Reconstructive Surgery documented that patients who lost more than 15 percent of body weight through bariatric surgery frequently reported worsened cellulite appearance despite overall fat reduction [6]. The mechanism: skin elasticity loss outpaced fat volume reduction.

GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) produce significant weight loss. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg produced 14.9 percent mean weight loss at 68 weeks versus 2.4 percent with placebo [7]. At that magnitude of loss, patients should anticipate potential changes in skin texture and cellulite distribution, particularly in the thighs and upper arms.

Aging, Collagen Degradation, and Dermal Thinning

Aging degrades all three layers relevant to cellulite: the dermis thins, septae stiffen, and fat lobule architecture loosens. These changes start earlier than most people realize.

Collagen production begins declining around age 25 at a rate of roughly 1 percent per year [4]. By age 50, cumulative collagen loss can reach 20 to 30 percent. The specific collagen types involved matter. Type I collagen provides tensile strength, while type III contributes elasticity. The ratio of type I to type III shifts with age, producing stiffer but thinner skin that transmits underlying fat irregularities more readily to the surface [8].

The fibrous septae themselves undergo fibrotic remodeling. A histological study in Dermatologic Surgery examined tissue samples from 20 women undergoing abdominoplasty and found that cellulite-affected areas contained septae with increased collagen density but decreased elastin content compared to non-affected areas [9]. The septae become rigid bands that pull the skin inward at fixed points while allowing fat to bulge between them.

"Cellulite is not simply a fat problem. It is a connective tissue problem with a fat component," wrote Dr. Mitchel Goldman in Cellulite: Pathophysiology and Treatment (2006) [10]. This distinction is clinically relevant because treatments targeting fat alone (liposuction, for example) can worsen cellulite by removing volume without addressing the tethering septae.

Glycation compounds the issue. Advanced glycation end products (AGEs) accumulate in collagen fibers over time, creating cross-links that reduce tissue flexibility [8]. Elevated blood glucose accelerates AGE formation, which means patients with insulin resistance or type 2 diabetes may experience faster progression of cellulite-related skin changes.

Genetics and Connective Tissue Architecture

Your genes determine septae orientation, fat lobule size, and dermal thickness. These heritable traits explain why cellulite severity varies dramatically among women of the same age, weight, and hormone status.

Twin studies suggest that genetic factors account for approximately 55 to 60 percent of cellulite predisposition [1]. The key inherited variable is septae geometry. Women with predominantly vertical septae (perpendicular to the skin surface) develop visible cellulite more readily than those with oblique or crisscross septae patterns. A 2009 MRI-based study in Skin Research and Technology imaged subcutaneous tissue in 80 women and confirmed that the number, thickness, and angulation of septae correlated more strongly with cellulite grade than BMI or total body fat percentage did [11].

ACE gene polymorphisms (specifically the insertion/deletion variant) have been associated with differences in connective tissue remodeling capacity [12]. The DD genotype, present in roughly 25 percent of the population, correlates with higher angiotensin-converting enzyme activity and potentially stiffer connective tissue. While research linking ACE variants directly to cellulite is still limited, the biological plausibility is strong given the enzyme's role in collagen metabolism.

Family history remains the most practical predictor. If your mother and maternal grandmother had prominent cellulite, your odds of experiencing similar or progressive changes increase substantially regardless of lifestyle factors.

Vascular and Lymphatic Contributions

Impaired microcirculation and sluggish lymphatic drainage create tissue edema that worsens the visible appearance of cellulite. This mechanism often explains why cellulite looks worse at certain times of day or month.

Capillary blood flow in cellulite-affected tissue is measurably reduced. A laser Doppler study published in Microvascular Research found that blood flow in grade 2 and 3 cellulite regions was 35 percent lower than in unaffected control areas of the same individuals [13]. Reduced perfusion leads to local hypoxia, which triggers fibrosis (septae thickening) and impairs waste removal from the interstitial space.

Lymphatic insufficiency compounds the vascular problem. The lymphatic system drains excess interstitial fluid and proteins from subcutaneous tissue. When drainage slows, fluid accumulates between fat lobules, increasing tissue turgor and making surface dimpling more pronounced [14]. This is why many women notice cellulite appearing worse after prolonged sitting, during premenstrual fluid retention, or in the evening after standing all day.

Chronic venous insufficiency (CVI) in the lower extremities can accelerate cellulite changes in the thighs. The backflow of venous blood increases hydrostatic pressure in capillary beds, driving more fluid into the interstitial space [13]. Compression stockings (20 to 30 mmHg) and regular calf-raise exercises can mitigate this component.

Medications and Iatrogenic Causes

Several commonly prescribed medications alter fat distribution, fluid balance, or connective tissue quality in ways that change cellulite appearance.

Systemic corticosteroids (prednisone, dexamethasone) taken for more than 4 weeks cause measurable skin thinning and subcutaneous fat redistribution. The Cushing-like fat pattern that glucocorticoids produce concentrates adipose tissue in the trunk while thinning limb subcutaneous layers, and the concurrent collagen degradation makes dimpling more apparent [15]. Patients on chronic prednisone doses above 7.5 mg daily should expect progressive skin changes that may include worsened cellulite.

Hormonal therapies affect cellulite through the estrogen pathway discussed earlier. Combined oral contraceptives that contain estrogen can increase subcutaneous fat deposition in estrogen-sensitive areas. Conversely, aromatase inhibitors used in breast cancer treatment (letrozole, anastrozole) suppress estrogen production dramatically and may accelerate dermal thinning [3].

Insulin and sulfonylureas promote weight gain. Patients switching to these agents from metformin or SGLT2 inhibitors often gain 2 to 5 kg in the first year, enough to shift cellulite grade in susceptible individuals [7]. If you notice cellulite changes coinciding with a medication change, that temporal correlation is diagnostically useful.

Evidence-Based Treatment Options

Treatment should match the dominant mechanism driving your cellulite changes. Subcision-based procedures target septae directly; energy devices address dermal thickness; weight management and hormonal optimization work on the fat and hormonal components.

Subcision and enzymatic release. The FDA approved collagenase clostridium histolyticum (QWO) in July 2020 for moderate-to-severe cellulite in the buttocks of adult women [16]. In the RELEASE-1 trial (N=843), QWO produced a statistically significant 2-level composite improvement on the Clinician-Reported Photonumeric Cellulite Severity Scale at day 71 compared to placebo (P<0.001) [16]. Manual subcision (Cellfina) uses a needle-based device to sever individual septae. A 3-year follow-up study in Dermatologic Surgery showed 93 percent patient satisfaction at 36 months post-treatment [9].

Radiofrequency and laser. Radiofrequency devices (Thermage, BTL Unison) heat the dermis to stimulate collagen remodeling. A randomized controlled trial of 50 women treated with monopolar radiofrequency reported a mean circumference reduction of 2.3 cm in treated thighs at 6 months, with 73 percent of patients showing at least one grade improvement [17].

Topical retinoids. Tretinoin 0.3 percent applied to cellulite-affected areas for 6 months increased dermal thickness by 0.8 mm in a small pilot study (N=20) published in Clinical and Experimental Dermatology [18]. The effect is modest but may complement procedural treatments.

Resistance training. Structured strength training reduces subcutaneous fat layer thickness while increasing muscle mass underneath. A 12-week RCT of 60 women performing lower-body resistance exercises three times weekly showed a 1.1-grade mean reduction on the Nürnberger-Müller scale versus 0.2 in controls [19].

When to See a Clinician

Most cellulite changes are cosmetic. Certain patterns, however, signal an underlying medical condition that needs evaluation.

Sudden, unilateral worsening of skin texture in one leg (but not the other) warrants assessment for deep venous thrombosis or lymphedema, particularly if accompanied by swelling, warmth, or pain [14]. Rapid cellulite changes across multiple body areas alongside new stretch marks, easy bruising, and central weight gain could indicate Cushing syndrome from endogenous cortisol overproduction or iatrogenic steroid use [15].

Cellulite that becomes indurated (hard to the touch), erythematous (red), or painful is not typical cellulite. It may represent cellulitis (a bacterial skin infection), panniculitis (inflammation of subcutaneous fat), or lipodermatosclerosis (a chronic inflammatory condition related to venous insufficiency) [14]. These conditions require medical treatment, not cosmetic intervention.

Schedule an appointment if your cellulite changes are asymmetric, painful, associated with systemic symptoms like fever or fatigue, or temporally linked to a new medication.